healthcareassoci
infect
hcai
continu
caus
major
burden
societi
affect
million
patient
annual
europ
alon
caus
estim
million
addit
bedday
respons
billion
direct
medic
cost
unit
kingdom
intervent
improv
hand
hygien
antibiot
stewardship
screen
combin
decolonis
believ
set
steep
reduct
report
incid
health
careassoci
methicillinresist
staphylococcu
aureu
mrsa
bacteraemia
clostridium
difficil
infect
peak
incid
respect
progress
reduc
burden
hcai
hinder
uncertainti
surround
role
asymptomat
carrier
environment
transmiss
recent
emerg
bacteria
mrsa
c
difficil
enterobacteriacea
eg
escherichia
coli
mathemat
model
increasingli
use
obtain
deeper
understand
epidemiolog
pattern
hospit
infect
guid
hospit
infect
control
polici
decis
seen
area
infecti
diseas
epidemiolog
previou
review
area
provid
insight
type
model
use
hospit
epidemiolog
highlight
capac
increas
epidemiolog
understand
inform
infect
control
polici
review
conduct
primarili
aim
explain
capac
model
therefor
limit
detail
descript
number
studi
henc
emerg
trend
area
fulli
explor
sinc
field
expand
consider
conduct
systemat
review
order
establish
mathemat
model
appli
field
hcai
model
method
develop
time
elig
studi
fulfil
follow
criteria
mathemat
model
hcai
transmiss
andor
dynam
antimicrobi
resist
dynam
transmiss
model
ie
model
track
number
individu
proport
popul
carri
infect
pathogen
time
captur
effect
contact
individu
transmiss
primari
focu
hcai
transmiss
healthcar
set
studi
exclud
involv
human
human
transmiss
involv
within
host
transmiss
pharmacodynam
pharmacokinet
drug
eg
impact
antibiot
exposur
explor
antibiot
toler
investig
fit
anim
transmiss
hcai
commun
transmiss
pathogen
spread
healthcar
environ
well
commun
spread
focu
paper
eg
sar
epidem
literatur
review
without
new
primari
studi
moreov
editori
letter
editor
includ
except
new
mathemat
model
introduc
although
hcai
often
associ
antibioticresist
bacteria
hcai
model
involv
antimicrobi
suscept
pathogen
well
review
studi
specifi
particular
pathogen
concern
claim
investig
antimicrobi
resist
bacteria
classifi
antimicrobi
resist
bacteria
arb
otherwis
studi
categoris
hcai
gener
moreov
major
patient
carri
hcai
mrsa
c
difficil
asymptomat
mani
mathemat
model
simul
epidemiolog
colonis
howev
breviti
refer
model
concern
epidemiolog
hcai
text
figur
show
mrsa
common
bacteri
speci
studi
studi
follow
vancomycinresist
enterococcu
vre
glycopeptideresist
enterococci
studi
wherea
c
difficil
rare
subject
model
studi
sever
studi
investig
dynam
one
pathogen
total
number
infect
agent
list
figur
exce
total
number
studi
first
model
hcai
conceptualis
spread
antibiot
resist
bacteri
popul
among
hospit
patient
soon
follow
model
evalu
effect
intervent
reduc
antibiot
resist
eg
antibiot
cycl
mix
sinc
hcai
model
aim
quantifi
infect
control
effect
studi
infect
control
measur
frequent
consid
among
paper
hand
hygien
studi
patient
isol
studi
hcw
cohort
studi
antibiot
stewardship
studi
screen
studi
figur
provid
overview
main
intervent
model
time
emphasis
decolonis
vaccin
recent
subject
studi
moreov
wider
variabl
intervent
evalu
later
year
tabl
illustr
type
intervent
evalu
hcai
pathogen
model
often
use
increas
epidemiolog
understand
hospit
surveil
data
frequent
use
inform
hcai
model
lack
detail
need
model
purpos
exampl
inform
asymptomat
carriag
time
event
eg
infect
often
lack
sever
studi
use
new
statist
method
overcom
difficulti
allow
estim
import
epidemiolog
paramet
eg
transmiss
rate
differ
data
sourc
vari
routin
collect
hospit
data
strain
type
genotyp
data
other
use
model
techniqu
determin
rel
import
potenti
transmiss
reservoir
acquisit
rout
c
difficil
vre
cephalosporinresist
enterobacteriacea
cre
sar
ecolog
dynam
pathogen
also
explor
use
model
includ
antimicrobi
resist
cocolonis
differ
pathogen
strain
type
competit
strain
anoth
recent
subject
studi
potenti
impact
readmiss
patient
set
longterm
care
facil
ltcf
commun
well
gener
movement
pattern
healthcar
institut
andor
commun
transmiss
mrsa
antimicrobi
resist
hcai
gener
econom
outcom
consid
dynam
transmiss
model
three
recent
paper
appli
dynam
model
techniqu
estim
econom
burden
diseas
mrsa
noroviru
investig
econom
incent
infect
control
invest
number
studi
studi
specifi
particular
nation
set
public
three
studi
explor
transmiss
hcai
lower
lower
middl
incom
countri
anoth
three
look
upper
middl
incom
china
studi
mainli
concentr
unit
state
studi
unit
kingdom
studi
netherland
studi
first
hcai
model
captur
transmiss
dynam
singl
ward
use
determinist
approach
popul
size
singl
ward
hospit
like
small
stochast
model
approach
may
often
appropri
take
account
role
chanc
determin
transmiss
pattern
tabl
definit
model
term
use
model
classif
provid
figur
show
proport
stochast
model
increas
steadili
time
figur
illustr
stochast
soon
introduc
public
first
determinist
hcai
model
sever
studi
develop
stochast
determinist
version
similar
compartment
model
investig
whether
project
intervent
effect
partli
result
random
fluctuat
other
use
determinist
model
interpret
find
stochast
model
infecti
diseas
model
either
aggreg
compartment
structur
track
group
popul
individualbas
structur
track
individu
latter
enabl
better
incorpor
heterogen
patient
characterist
patient
demograph
contact
pattern
diseas
histori
cost
increas
comput
burden
date
studi
hcai
model
taken
aggreg
approach
although
proport
individualbas
model
increas
time
figur
total
public
took
individualbas
approach
seven
paper
use
compartment
individualbas
model
model
paramet
valu
base
exist
studi
assumpt
estim
directli
data
unknown
paramet
infect
transmiss
rate
infer
calibr
model
empir
data
increas
avail
comput
power
numericallyintens
statist
method
paramet
infer
becom
access
figur
show
although
studi
hcai
model
incorpor
sort
calibr
process
empir
data
proport
increas
time
metric
use
quantifi
good
fit
includ
least
squar
criterion
minimis
sum
squar
observ
data
model
predict
maximum
likelihood
estim
identif
paramet
valu
make
observ
data
like
sinc
bayesian
method
frequent
use
markov
chain
mont
carlo
mcmc
approach
combin
mcmc
maximum
likelihood
estim
seven
studi
report
fit
model
compar
model
predict
observ
epidemiolog
data
appli
formal
quantit
approach
infecti
diseas
model
develop
inform
use
combin
avail
evid
exampl
infect
transmiss
diseas
natur
histori
intervent
effect
avail
inform
unlik
complet
mathemat
model
inher
includ
degre
uncertainti
uncertainti
may
relat
model
paramet
valu
model
structur
eg
term
diseas
state
incorpor
relationship
methodolog
use
paramet
uncertainti
investig
studi
public
figur
illustr
similar
trend
seen
applic
formal
model
calibr
appli
inclus
paramet
uncertainti
also
method
use
paramet
uncertainti
becom
complex
time
figur
studi
investig
paramet
uncertainti
univari
sensit
analysi
ie
alter
one
paramet
time
whilst
hold
other
basecas
valu
conduct
studi
comput
expens
probabilist
sensit
analysi
formul
uncertainti
model
input
joint
probabl
distribut
propag
uncertainti
output
gener
consid
rigor
method
account
uncertainti
joint
distribut
paramet
employ
studi
among
latin
hypercub
sampl
lh
mean
perform
probabilist
sensit
analysi
conduct
four
studi
probabilist
sensit
analysi
util
lh
provid
rigor
method
incorpor
repres
real
uncertainti
surround
paramet
estim
modelbas
analysi
joint
probabl
distribut
paramet
avail
model
valid
rare
hcai
model
ideal
model
valid
mean
compar
model
predict
observ
altern
dataset
one
use
model
fit
although
often
difficult
practic
four
studi
report
kind
model
valid
base
least
two
differ
data
set
howev
one
studi
use
statist
approach
wherea
other
includ
subject
comparison
model
predict
infect
transmiss
genotyp
data
mathemat
model
hcai
primarili
set
singl
ward
studi
intens
care
unit
icu
frequent
set
model
studi
simplifi
hospit
set
lack
ward
structur
studi
recent
studi
howev
incorpor
interact
gener
ward
icu
differ
ward
although
ward
hospitalbas
model
usual
treat
hospit
close
system
ie
hospit
admiss
discharg
rate
gener
commun
frequent
includ
transfer
pattern
healthcar
institut
rare
consid
transmiss
dynam
within
set
outsid
healthcar
facil
interact
commun
hospit
transmiss
includ
mrsa
antimicrobi
resist
bacteria
whole
sever
acut
respiratori
syndrom
tuberculosi
henc
possibl
longterm
feedback
hospit
set
taken
account
two
model
concern
nosocomi
transmiss
ltcf
set
alon
ie
influenza
noroviru
respect
model
mrsa
transmiss
domin
literatur
follow
vre
although
consider
lesser
extent
subject
nation
surveil
infect
control
polici
varieti
develop
countri
may
account
rel
abund
model
studi
despit
caus
high
burden
subject
nation
control
polici
c
difficil
transmiss
seldom
model
similarli
bloodstream
infect
due
thirdgener
cephalosporinresist
e
coli
estim
caus
excess
death
extra
bed
day
europ
consid
one
studi
comparison
mrsa
estim
caus
death
addit
bed
day
europ
yet
subject
studi
seem
occurr
model
necessarili
correl
burden
diseas
also
true
low
middl
incom
countri
recent
publish
systemat
review
demonstr
significantli
higher
preval
hcai
high
incom
countri
howev
model
studi
tackl
problem
hcai
less
develop
set
term
model
method
consider
chang
identifi
time
introduct
first
determinist
hcai
model
studi
inclus
stochast
becom
common
practic
major
hcai
model
evalu
infect
control
polici
sound
model
parameteris
sensit
analys
requir
reliabl
predict
use
sophist
method
model
parameteris
eg
mcmc
uncertainti
analysi
becom
increasingli
common
hcai
model
also
increas
complex
regard
set
model
although
major
model
consid
singl
ward
often
icu
appar
emerg
transmiss
typic
hcai
commun
particular
mrsa
result
model
consid
transmiss
hcai
holist
approach
longterm
feedback
loop
relat
hospit
discharg
readmiss
colonis
patient
spread
hcai
pathogen
commun
set
ltcf
effect
hcai
transmiss
dynam
approach
aid
provid
realist
estim
exist
new
infect
control
strategi
effect
review
limit
first
exclus
consid
peerreview
public
english
might
result
slight
inaccuraci
result
eg
regard
model
particular
pathogen
altern
nation
set
exclus
interest
model
explor
patienttopati
transmiss
hcai
antimicrobi
resist
within
healthcar
set
either
directli
mediat
healthcar
worker
andor
healthcar
environ
result
exclus
higher
number
model
elucid
dynam
antimicrobi
resist
right
summaris
elsewher
moreov
review
intend
provid
overal
trend
field
hcai
model
rather
detail
account
qualiti
individu
model
model
shown
could
valid
futur
area
investig
compartment
model
group
individu
class
predomin
field
hcai
model
emerg
individualbas
model
allow
realist
model
healthcar
workerpati
contact
eg
super
spread
event
incorpor
heterogen
transmiss
risk
profil
patient
howev
approach
comput
far
intens
difficult
fit
data
inclus
addit
factor
make
demand
data
avail
detail
level
data
observ
healthcar
workerpati
contact
collect
exampl
via
motebas
sensor
network
done
recent
could
help
parameteris
complex
model
moreov
recent
technolog
develop
microbiolog
result
enhanc
access
pathogen
sequenc
data
could
help
improv
hcai
model
data
begin
inform
diseas
outbreak
eg
avian
influenza
footandmouth
diseas
importantli
increasingli
routin
use
sequenc
genet
materi
epidemiolog
purpos
provid
valuabl
insight
aid
understand
role
asymptomat
carrier
transmiss
eg
c
difficil
evolut
antimicrobi
resist
transmiss
model
concern
hcai
show
gener
enhanc
complex
almost
complet
limit
highincom
set
strongli
focus
mrsa
transmiss
hospit
set
improv
avail
data
statist
method
could
enhanc
insight
gain
model
arb
antimicrobi
resist
bacteria
cre
cephalosporinresist
enterobacteriacea
esbl
extendedspectrum
betalactamas
hcai
healthcareassoci
infect
icu
intens
care
unit
ili
influenzalik
ill
lh
latin
hybercub
sampl
ltcf
longterm
care
facil
mcmc
markov
chain
mont
carlo
mrsa
methicillinresist
staphylococcu
aureu
rgnr
third
gener
cephalosporinresist
gramneg
rod
tb
tuberculosi
vre
vancomycinresist
enterococcu
author
declar
compet
interest
evk
develop
search
strategi
collabor
jr
conduct
titleabstract
screen
independ
share
titleabstract
screen
mj
sd
wje
full
text
evalu
conduct
evk
case
uncertainti
discuss
took
place
jr
evk
wrote
manuscript
signific
contribut
author
author
read
approv
final
manuscript
prepubl
histori
paper
access
http
